New Study On Prevention Of Transfer Of HIV

New Study On Prevention Of Transfer Of HIV.
An antiviral antidepressant may assist conserve injection drug users from HIV infection, a rejuvenated study finds. The study of more than 2400 injection stimulant users recruited at 17 drug treatment clinics in Thailand found that constantly tablets of tenofovir reduced the risk of HIV infection by nearly 49 percent, compared to supine placebo pills anxiety. One crack said an intervention to help shield injection deaden users from HIV - the virus that causes AIDS - is much needed.

And "This is an prominent study that opens up an additional alternative for preventing HIV in a hard-to-reach population," said Dr Joseph McGowan, medical official at the Center for AIDS Research and Treatment at North Shore University Hospital in Manhasset, NY. He celebrated that "HIV infections at to manifest itself at high rates, with over 2,5 million worldwide and 50000 original infections in the US each year. This is teeth of widespread knowledge about HIV infection and the way it is spread, through unprotected going to bed and sharing needles for injecting drugs".

The participants included in the experimental study were followed for an average of four years. During that time, 17 of the more than 1200 patients taking tenofovir became infected with HIV, compared with 33 of an matching horde of patients taking a placebo, according to the consider published online June 12, 2013 in The Lancet. Further analyses of the results showed that the careful effect of tenofovir was highest to each those who most closely followed the drug's prescribed regimen.

In this group, the chance of HIV infection was reduced by more than 70 percent, said contemplation leaders Dr Kachit Choopanya and Dr Michael Martin, leading of clinical research for the Thailand Ministry of Public Health-US Centers for Disease Control and Prevention Collaboration. Prior fact-finding has shown that countermeasure use of antiviral drugs cuts the imperil of sexual transmission of HIV in both heterosexual couples and men who have relations with men, and also reduces mother-to-child transmission of HIV.

But this is the beginning study to show that this approach might also be effective among injection poison users. Worldwide, injection drug use is believed to cause one in 10 redesigned HIV infections. But rates of infection associated with injection medication use are far higher in some areas of the world, such as eastern Europe and prime Asia.

In these regions, up to 80 percent of different HIV infections are caused by injection drug use. According to McGowan, tenofovir is no "silver bullet" that would, on its own, rub out the hazard of HIV infection for drug abusers. But it could be a level ingredient in reducing the odds.

So "Adoption of this strategy, not as a stand-alone, but in conjunction with needle exchange, counseling, opiate substitution, venereal backing and mental health therapy may enable us to get at the of this expanding epidemic". He added that the participants in the study were also provided with what's known as "directly observed therapy," where the remedy is administered under the adherence of a health care worker.

Services like this, along with monthly HIV testing and condom distribution, might not turn up in "real life" healing situations so outcomes might not be as good as in this clinical trial. Another ace agreed that adherence to tenofovir analysis is key to success neosize xl shop. Tenofovir "accumulates slowly in the body, making the envelope for adherence - which is strongly associated with the efficacy of the drug," said Victoria Richards, auxiliary professor of medical sciences at the Frank H Netter MD School of Medicine at Quinnipiac University, in Hamden, Conn.